Outcomes in the OCEANIC-STROKE Randomized, Placebo-Controlled Trial: FXIa Inhibition by Asundexian in Participants With Non-Cardioembolic Stroke or Transient Ischemic Attack by Non-Laboratory Framingham Risk Score Category - AHA OnDemand Skip to main content

The accreditors of this session require that you periodically check in to verify that you are still attentive. Please click the button below to indicate that you are.






Evaluation